Citation

Mark W. Kline, M.D., Russell B. Van Dyke, M.D., Jane C. Lindsey, Sc.D., Meg Gwynne, B.A., Mary Culnane, C.R.N.P., M.S., Clemente Diaz, M.D., Ram Yogev, M.D., Ross E. McKinney, Jr., M.D., Elaine J. Abrams, M.D., Lynne M. Mofenson, M.D., F.A.A.P. Combination Therapy with Stavudine (d4T) Plus Didanosine (ddI) In Children With Human Immunodeficiency Virus Infection. Pediatrics. 1999 May 01; 103(5):e62.

Citation

William T. Shearer, M.D., Ph.D., Mark W. Kline, M.D., Stuart L. Abramson, M.D., Ph.D., Terence Fenton, Ed.D., Stuart E. Starr, M.D., Steven D. Douglas, M.D. Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-infected Children: Safety, CD4+ Lymphocyte Count, Viral Load, and Neutrophil Function (AIDS Clinical Trials Group Protocol 211). Clinical and Diagnostic Laboratory Immunology. 1999 May 01; 6(3):311-15.

Citation

Stevens RC, Frenkel LM, Rodman JH. Influence Of Age and Food On Didanosine Pharmacokinetics In HIV Infected Children. Pharmacotherapy. 1999 Nov 30; 19:487.

Citation

Shapiro DE, Sperling RS, Coombs RW. Effect Of Zidovudine On Perinatal HIV-1 Transmission and Maternal Viral Load (Letter). Lancet. 1999 Jul 10; 354(9173):156.

Citation

GD McSherry, David E. Shapiro, Ph.D., RW Coombs, N Mcgrath, LM Frenkel, Britto P, M Culnane, RS Sperling. The Effects of Zidovudine in the Subset of Infants Infected with Human Immunodeficiency Virus Type-1. Journal of Pediatrics. 1999 Jun 01; 134(6):717-24.

Citation

Mark Mirochnick, Edmund Capparelli, James Connor. Pharmacokinetics of Zidovudine in Infants: A Population Analysis Across Studies. Clinical Pharmacology & Therapeutics. 1999 Jan 01; 66(1):16-24.

Citation

I. Celine Hanson, Tracy A. Antonelli, Rhoda S. Sperling, James M. Oleske, Ellen Rae Cooper, M.P.H., M.D., Mary Culnane, Mary Glenn Fowler, Leslie A. Kalish, Sophia S. Lee, George McSherry, Lynne Mofenson, David E. Shapiro. Lack of tumors in infants with perinantal HIV-1 exposure and fetal/neonatal exposure to zidovudine. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1999 Apr 15; 20(5):463-467.

Citation

Mary Culnane, C.R.N.P., M.S., Bethann Cunningham-Schrader, B.A., M.S., James M. Oleske, M.D., Mary Glenn Fowler, M.D., M.P.H., Sophia S. Lee, M.S., George D. McSherry, M.D., Michael T. Brady, M.D., Karen J. O'Donnell, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Steven Gortmaker, Ph.D., David E. Shapiro, Ph.D. Late Effects Of In Utero Exposure To Zidovudine Among Uninfected Infants Born To HIV-Infected Women. The Journal of the American Medical Association. 1999 Jan 13; 281(2):151-57.

Citation

Stuart E. Starr, Courtney V. Fletcher, Stephen A. Spector, Florence H. Yong, Terence Fenton, Richard C. Brundage, Douglas Manion, Nancy M. Ruiz, Merril Gersten, Mark Becker, James McNamara, Lynne M. Mofenson, Lynne M. Mofenson, M.D., F.A.A.P. Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse-Transcriptase Inhibitors In Children Infected With Human Immunodeficiency Virus Type-1. New England Journal of Medicine. 1999 Dec 16; 341(25):1874-81.